Sort   by:  
 Page size 
TranscriptomicsAR variant ARv567es induces carcinogenesis in a novel transgenic mouse model of prostate cancer.
Androgen deprivation therapy remains the primary treatment modality for patients with metastatic prostate cancer but is uniformly marked by progression to castration-resistant prostate cancer (CRPC) after a period of regression. Continued activation of androgen receptor (AR) signaling is attributed ...
ORGANISM(S): Mus musculus 
2014-09-11 | E-GEOD-61303 | biostudies-arrayexpress
TranscriptomicsMicroRNA profiling by array of acute myeloid leukemia patient samples for analysis of miR-29b expression
microRNA microarray data used for analysis of miR-29b expression in AML patient samples
ORGANISM(S): Homo sapiens 
2011-03-16 | E-TABM-944 | biostudies-arrayexpress
UnknownTrial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
Not available
S-EPMC4872347 | biostudies-literature
UnknownBlood pressure regulation by CD4+ lymphocytes expressing choline acetyltransferase.
Not available
S-EPMC5513182 | biostudies-literature
GenomicPROstate Cancer Medically Optimized Genome Enhanced ThErapy (PROMOTE)

The Prostate Cancer Medically Optimized Genome-Enhanced Therapy (PROMOTE) study uses genetic clues in castration-resistant prostate cancer that may identify an individualized treatment approach for men with the disease.

Understanding the molecular biology behind castration-resistant prosta...

phs001141 | dbGaP
UnknownPost Discharge after Surgery Virtual Care with Remote Automated Monitoring Technology (PVC-RAM): protocol for a randomized controlled trial.
Not available
S-EPMC8034369 | biostudies-literature
UnknownHLA-B*15:01-positive severe COVID-19 patients lack CD8<sup>+</sup> T cell pools with highly expanded public clonotypes.
Not available
S-EPMC12435269 | biostudies-literature
UnknownThe global, regional, and national burden of cancer, 1990-2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023.
Not available
S-EPMC12687902 | biostudies-literature
GenomicsICGC Benchmark 1 (CLL) - samples
Raw fastq files from WGS sequencing of CLL and matching blood normal for the ICGC Techval Benchmark1 study. Sequence data was provided to multiple centers for independent analysis and comparison.
EGAD00001001858 | EGA
GenomicsICGC Benchmark 2 (Medulloblastoma) - samples
Raw fastq files for sequence data generated at 5 sequencing centers from a Medulloblastoma sample and matching blood normal control.
EGAD00001001859 | EGA
Sort   by:  
 Page size